A PHASE-II TRIAL OF MITOMYCIN IN PATIENTS WITH EPITHELIAL OVARIAN-CARCINOMA RESISTANT TO CISPLATIN OR CARBOPLATIN

被引：6

作者：

HOSKINS, PJ

MCMURTRIE, E

SWENERTON, KD

机构：

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1990年 / 13卷 / 05期

关键词：

D O I：

10.1097/00000421-199010000-00010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Intravenous bolus mitomycin was given at a dose of 10-12 mg/m2 to patients with epithelial ovarian cancer resistant to cisplatin or carboplatin. There were three (12%) partial responses and no complete responses in the 25 patients so treated.

引用

页码：416 / 419

页数：4

共 16 条

[1] ALBERTS DS, 1988, SEMIN ONCOL, V15, P22
[2] ROLE OF ETOPOSIDE-BASED CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH REFRACTORY OR RELAPSING GERM-CELL TUMORS
BOSL, GJ
YAGODA, A
GOLBEY, RB
WHITMORE, W
HERR, H
SOGANI, P
MORSE, M
VOGELZANG, N
MACDONALD, G
[J]. AMERICAN JOURNAL OF MEDICINE, 1985, 78 (03) : 423 - 428
[3] BUXTON EJ, 1989, CANCER IMMUNOL IMM S, V28, pC22
[4] CREECH RH, 1985, CANCER TREAT REP, V69, P1271
[5] EISENHAUER EA, 1986, CANCER TREAT REP, V70, P1195
[6] SUCCESSFUL TREATMENT OF RESISTANT GERMINAL NEOPLASMS WITH VP-16 AND CISPLATIN - RESULTS OF A SOUTHEASTERN CANCER STUDY-GROUP TRIAL
HAINSWORTH, JD
WILLIAMS, SD
EINHORN, LH
BIRCH, R
GRECO, FA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (05) : 666 - 671
[7] International Federation of Gynecology and Obstetrics (FIGO), 1987, AM J OBSTET GYNECOL, V56, P263
[8] LAWTON FG, 1986, CANCER TREAT REP, V70, P525
[9] MANGIONI C, 1985, P ASCO, V4, P117
[10] RANDOMIZED TRIAL COMPARING 2 COMBINATION CHEMOTHERAPY REGIMENS (CHAP-5 V CP) IN ADVANCED OVARIAN-CARCINOMA
NEIJT, JP
TENBOKKELHUININK, WW
VANDERBURG, MEL
VANOOSTEROM, AT
WILLEMSE, PHB
HEINTZ, APM
VANLENT, M
TRIMBOS, JB
BOUMA, J
VERMORKEN, JB
VANHOUWELINGEN, JC
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (08) : 1157 - 1168

← 1 2 →